Mucosal changes induced by experimental pneumococcal otitis media are prevented by penicillin V

Area of Science:

• Otolaryngology
• Microbiology
• Pharmacology

Background:

• Untreated pneumococcal acute otitis media (AOM) in rats leads to persistent middle ear mucosal damage.
• Understanding the long-term effects of AOM is crucial for developing effective treatments.

Purpose of the Study:

• To evaluate the efficacy of Penicillin V (pcV) in preventing and treating structural changes in the middle ear mucosa during AOM.
• To compare the effects of prophylactic vs. early treatment with pcV on AOM-induced mucosal alterations.

Main Methods:

• Administered pcV to rats either before (prevention) or after (early treatment) bacterial challenge.
• Collected middle ear mucosa samples at multiple time points (days 4, 8, 12, and 2, 6 months post-challenge) for light microscopy.
• Compared mucosal changes in treated groups against untreated infected control rats.

Main Results:

• Both prevention and early treatment groups showed diminished structural changes compared to untreated controls.
• Persistent structural changes observed at 6 months in untreated rats were absent in pcV-treated animals.
• Early pcV treatment demonstrated nearly equivalent effectiveness to prophylactic administration in preventing long-term mucosal changes.

Conclusions:

• Penicillin V significantly mitigates persistent structural damage to the middle ear mucosa following acute otitis media in a rat model.
• Early therapeutic intervention with Penicillin V is a viable strategy for managing AOM-related mucosal pathology.
• The findings support the use of Penicillin V for both preventing and treating the long-term consequences of bacterial otitis media.